The effects of acute carbohydrate and caffeine feeding strategies on cycling efficiency

To assess the effect of carbohydrate and caffeine on gross efficiency (GE), 14 cyclists (V? O2max 57.6 ± 6.3 ml.kg?1.min?1) completed 4 × 2-hour tests at a submaximal exercise intensity (60% Maximal Minute Power). Using a randomized, counter-balanced crossover design, participants con- sumed a standardised diet in the 3-days preceding each test and subsequently ingested either caffeine (CAF), carbohydrate (CHO), caffeine+carbohydrate (CAF+CHO) or water (W) during exercise whilst GE and plasma glucose were assessed at regular intervals (~30 mins). GE progressively decreased in the W condition but, whilst caffeine had no effect, this was significantly attenuated in both trials that involved carbohydrate feedings (W = ?1.78 ± 0.31%; CHO = ?0.70 ± 0.25%, p = 0.008; CAF+CHO = ?0.63 ± 0.27%, p = 0.023; CAF = ?1.12 ± 0.24%, p = 0.077). Blood glucose levels were significantly higher in carbohydrate ingestion conditions (CHO = 4.79 ± 0.67 mmol·L?1, p < 0.001; CAF +CHO = 5.05 ± 0.81 mmol·L?1, p < 0.001; CAF = 4.46 ± 0.75 mmol·L?1; W = 4.20 ± 0.53 mmol·L?1). Carbohydrate ingestion has a small but significant effect on exercise-induced reductions in GE, indicat- ing that cyclists’ feeding strategy should be carefully monitored prior to and during assessment

High Agreement between Laboratory and Field Estimates of Critical Power in Cycling

The purpose of this study was to investigate the level of agreement between laboratory-based estimates of critical power (CP) and results taken from a novel field test. Subjects were fourteen trained cyclists (age 40±7 yrs; body mass 70.2±6.5 kg; V?O2max 3.8±0.5 L · min-1). Laboratory-based CP was estimated from 3 constant work-rate tests at 80%, 100% and 105% of maximal aerobic power (MAP). Field-based CP was estimated from 3 all-out tests performed on an outdoor velodrome over fixed durations of 3, 7 and 12 min. Using the linear work limit (Wlim) vs. time limit (Tlim) relation for the estimation of CP1 values and the inverse time (1/t) vs. power (P) models for the estimation of CP2 values, field-based CP1 and CP2 values did not significantly differ from laboratory-based values (234±24.4 W vs. 234±25.5 W (CP1); P<0.001; limits of agreement [LOA], -10.98-10.8 W and 236±29.1 W vs. 235±24.1 W (CP2); P<0.001; [LOA], -13.88-17.3 W. Mean prediction errors for laboratory and field estimates were 2.2% (CP) and 27% (W'). Data suggest that employing all-out field tests lasting 3, 7 and 12 min has potential utility in the estimation of CP

Validity and reliability of critical power field testing

PURPOSE To test the validity and reliability of field critical power (CP). METHOD Laboratory CP tests comprised three exhaustive trials at intensities of 80, 100 and 105 % maximal aerobic power and CP results were compared with those determined from the field. Experiment 1: cyclists performed three CP field tests which comprised maximal efforts of 12, 7 and 3 min with a 30 min recovery between efforts. Experiment 2: cyclists performed 3 × 3, 3 × 7 and 3 × 12 min individual maximal efforts in a randomised order in the field. Experiment 3: the highest 3, 7 and 12 min power outputs were extracted from field training and racing data. RESULTS Standard error of the estimate of CP was 4.5, 5.8 and 5.2 % for experiments 1-3, respectively. Limits of agreement for CP were -26 to 29, 26 to 53 and -34 to 44 W for experiments 1-3, respectively. Mean coefficient of variation in field CP was 2.4, 6.5 and 3.5 % for experiments 1-3, respectively. Intraclass correlation coefficients of the three repeated trials for CP were 0.99, 0.96 and 0.99 for experiments 1-3, respectively. CONCLUSIONS Results suggest field-testing using the different protocols from this research study, produce both valid and reliable CP values

Comparison of inter-trial recovery times for the determination of critical power and W' in cycling.

Critical Power (CP) and W' are often determined using multi-day testing protocols. To investigate this cumbersome testing method, the purpose of this study was to compare the differences between the conventional use of a 24-h inter-trial recovery time with those of 3 h and 30 min for the determination of CP and W'. METHODS: 9 moderately trained cyclists performed an incremental test to exhaustion to establish the power output associated with the maximum oxygen uptake (p[Formula: see text]max), and 3 protocols requiring time-to-exhaustion trials at a constant work-rate performed at 80%, 100% and 105% of p[Formula: see text]max. Design: Protocol A utilised 24-h inter-trial recovery (CP24/W'24), protocol B utilised 3-h inter-trial recovery (CP3/W'3), and protocol C used 30-min inter-trial recovery period (CP0.5/W'0.5). CP and W' were calculated using the inverse time (1/t) versus power (P) relation (P = W'(1/t) + CP). RESULTS: 95% Limits of Agreement between protocol A and B were -9 to 15 W; -7.4 to 7.8 kJ (CP/W') and between protocol A and protocol C they were -27 to 22 W; -7.2 to 15.1 kJ (CP/W'). Compared to criterion protocol A, the average prediction error of protocol B was 2.5% (CP) and 25.6% (W'), whilst for protocol C it was 3.7% (CP) and 32.9% (W'). CONCLUSION: 3-h and 30-min inter-trial recovery time protocols provide valid methods of determining CP but not W' in cycling

Modelling of critical power from road data

Background: Performance tests are an integral part of evaluating competitive cyclists. Despite all technological and physiological advances, limited research has been performed addressing the translation of standardized, relevant laboratory tests into the field and consequently into “real world” cycling (i.e. .(i.e. González-Haro et al., 2007: British Journal of Sports Medicine, 41(3), 174–179; Quod et al., 2010:InterInternational Journal of Sports Medicine, 31(6), 397–401; Nimmerichter et al., 2010: International Journal of Sports Medicine, 31(3), 160- 166). For continuous activities between approximately 2 and 30 minutes, the assessment of Critical Power (CP) is one such relevant test. Compromising ecological validity, to date CP testing is mostly constrained to the laboratory. Purpose: To investigate a novel CP road testing protocol. Methods: Laboratory determined CP values using a 30 min intra-trial recovery period (Bishop & Jenkins, 1995: European Journal of Applied Physiology and Occupational Physiology, 72 (1-2), 115-120) were compared with those determined in the field, i.e. on the road. The experiment comprised of planned maximal efforts of 12 min, 7 min and 3 min with a 30 min recovery period between efforts. Linear regression was used to determine CP using the work- Results: There was no significant difference between laboratory and road CP values. The mean difference between the two environments was 0 ± 5.5 W. The standard error of estimates was 1.7% and limits of agreement were -10.8 – 10.8 W (Fig. 1). Discussion: Results suggests that CP can be tested on the road. Gonzales-Haro accepted their incremental velodrome field test as being valid with reported limits of agreement of 130 W to – 24 W and a random error of 13.9%. Our limits of agreement values are considerably higher and standard error of estimate values are considerably lower than those reported by Gonzales-Haro. The experimental protocol provides a practical and easy to use alternative to the conventional testing protocol for coaches and athletes when determining CP in on the road. Conclusion: The aforementioned research provides support for the acceptance of road CP performance testing using a 30 min inter-maximal effort recovery period

Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors

Purpose: This study investigated the effect of ischemic preconditioning (IP) on metaboreflex activation following dynamic leg extension exercise in a group of healthy participants. Method: Seventeen healthy participants were recruited. IP and SHAM treatments (3 × 5 min cuff occlusion at 220 mmHg or 20 mmHg, respectively) were administered in a randomized order to the upper part of exercising leg’s thigh only. Muscle pain intensity (MP) and pain pressure threshold (PPT) were monitored while administrating IP and SHAM treatments. After 3 min of leg extension exercise at 70% of the maximal workload, a post-exercise muscle ischemia (PEMI) was performed to monitor the discharge group III/IV muscle afferents via metaboreflex activation. Hemodynamics were continuously recorded. MP was monitored during exercise and PEMI. Results: IP significantly reduced mean arterial pressure compared to SHAM during metaboreflex activation (mean ± SD, 109.52 ± 7.25 vs. 102.36 ± 7.89 mmHg) which was probably the consequence of a reduced end diastolic volume (mean ± SD, 113.09 ± 14.25 vs. 102.42 ± 9.38 ml). MP was significantly higher during the IP compared to SHAM treatment, while no significant differences in PPT were found. MP did not change during exercise, but it was significantly lower during the PEMI following IP (5.10 ± 1.29 vs. 4.00 ± 1.54). Conclusion: Our study demonstrated that IP reduces hemodynamic response during metaboreflex activation, while no effect on MP and PPT were found. The reduction in hemodynamic response was likely the consequence of a blunted venous return

The 3-min Test Does not Provide a Valid Measure of Critical Power Using the SRM Isokinetic Mode

Recent datas suggest that the mean power over the final 30 s of a 3-min all-out test is equivalent to Critical Power (CP) using the linear ergometer mode. The purpose of the present study was to identify whether this is also true using an "isokinetic mode". 13 cyclists performed: 1) a ramp test; 2) three 3-min all-out trials to establish End Power (EP) and work done above EP (WEP); and 3) 3 constant work rate trials to determine CP and the work done above CP (W') using the work-time (=CP1/W'1) and 1/time (=CP2/W'2) models. Coefficient of variation in EP was 4.45% between trials 1 and 2, and 4.29% between trials 2 and 3. Limits of Agreement for trials 1-2 and trials 2-3 were -2±38 W. Significant differences were observed between EP and CP1 (+37 W, P<0.001), between WEP and W'1(-6.2 kJ, P=0.001), between EP and CP2 (+31 W, P<0.001) and between WEP and W'2 (-4.2 kJ, P=0.006). Average SEE values for EP-CP1 and EP-CP2 of 7.1% and 6.6% respectively were identified. Data suggest that using an isokinetic mode 3-min all-out test, while yielding a reliable measure of EP, does not provide a valid measure of CP

Placebo effect of an inert gel on experimentally induced leg muscle pain

Purpose: This study examined the therapeutic effects of an inert placebo gel on experimentally induced muscle pain in a sports therapy setting. It aimed to investigate the degree to which conditioned analgesia, coupled with an expectation of intervention, was a factor in subsequent analgesia. Methods: Participants were sixteen male and eight female sports therapy students at a UK University. With institutional ethics board approval and following informed consent proce- dures, each was exposed to pain stimulus in the lower leg in five conditions, ie, conditioning, prebaseline, experimental (two placebo gel applications), and postbaseline. In conditioning trials, participants identified a level of pain stimulus equivalent to a perceived pain rating of 6/10. An inert placebo gel was then applied to the site with the explicit instruction that it was an analgesic. Participants were re-exposed to the pain stimulus, the level of which, without their knowledge, had been decreased, creating the impression of an analgesic effect resulting from the gel. In experimental conditions, the placebo gel was applied and the level of pain stimulus required to elicit a pain rating of 6/10 recorded. Results: Following application of the placebo gel, the level of pain stimulus required to elicit a pain rating of 6/10 increased by 8.2%. Application of the placebo gel significantly decreased participant’s perceptions of muscle pain (P = 0.001). Conclusion: Subjects’ experience and expectation of pain reduction may be major factors in the therapeutic process. These factors should be considered in the sports therapeutic environment

Physical and Mental Fatigue Reduce Psychomotor Vigilance in Professional Football Players

Purpose: Professional football players experience both physical and mental fatigue (MF). The main aims of this randomized crossover study were to investigate the effect of MF on repeated-sprint ability (RSA) and the effects of both physical fatigue and MF on psychomotor vigilance. Methods: Seventeen male professional football players performed 10 maximal 20-m shuttle sprints interspaced by incomplete recovery (RSA test). Running speed, heart rate, brain oxygenation, and rating of perceived exertion were monitored during each sprint. The RSA test was preceded by either a 30-minute Stroop task to induce MF or by watching a documentary for 30 minutes (control [CON]) in a randomized counterbalanced order. Participants performed a psychomotor vigilance test at baseline, after the cognitive task (MF or CON), and after the RSA test. Results: Heart rate and rating of perceived exertion significantly increased, while running speed and brain oxygenation significantly decreased over the repeated sprints (P .001) with no significant differences between conditions. Response speed during the psychomotor vigilance test significantly declined after the Stroop task but not after CON (P = .001). Response speed during the psychomotor vigilance test declined after the RSA test in both conditions (P .001) and remained lower in the MF condition compared to CON (P = .012). Conclusions: MF does not reduce RSA. However, the results of this study suggest that physical fatigue and MF have negative and cumulative effects on psychomotor vigilance. Therefore, strategies to reduce both physical fatigue and MF should be implemented in professional football players